Special Issue "Pharmacological Treatments for Osteoarthritis"
Deadline for manuscript submissions: closed (31 May 2023) | Viewed by 3373
Interests: arthritis; macrophage polarization; pro-resolving mediators; efferocytosis; resolution of inflammation
Interests: arthritis; chemokine; resolution of inflammation; inflammatory pain
Special Issues, Collections and Topics in MDPI journals
Osteoarthritis (OA) is the most common form of arthritis, and it is one of the leading causes of disability worldwide. This disorder is characterized by severe degeneration of articular cartilage in load-bearing joints, including the knees, hips, and hands. For many years, OA was considered a ‘wear and tear’ disease, but recent studies have shown that signs of low-grade synovial inflammation affect 50-80% of patients, contributing to disease progression and symptoms. This disease has been considered the major cause of chronic pain in adults, becoming a substantial personal and socioeconomic burden. Thus far, no disease-modifying drugs are available to stop or slow its process. Symptoms alleviation and final joint replacement in the advanced disease stage are the main treatment options available. Efforts have been made to identify treatment options with the aim of developing more effective therapeutic strategies to treat OA. In this regard, the journal Pharmaceuticals invites authors to submit their original research and review articles on experimental and clinical studies. Topics consist of potential pharmacological therapies to treat OA, including potential disease-modifying OA drugs (DMOADs) and new therapies to relieve pain. The collection of manuscripts will be published as a Special Issue of the journal.
Dr. Juliana Priscila Vago
Prof. Dr. Flavio A. Amaral
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- synovial inflammation
- cartilage degradation